Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST
Clinical trial NCT02413736 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02413736
- Sponsor
- Heikki Joensuu
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2026-06-01
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.